Amphotericin forms an extramembranous and fungicidal sterol sponge

Area of Science:

• Biochemistry
• Mycology
• Antimicrobial drug development

Background:

• Amphotericin is a critical antifungal drug, but its high toxicity limits its use.
• Understanding amphotericin's mechanism is vital for developing safer alternatives and overcoming resistance.
• Existing models propose amphotericin forms ion channels to kill fungal cells.

Purpose of the Study:

• To elucidate the precise mechanism by which amphotericin exerts its antifungal activity.
• To investigate the role of ergosterol in amphotericin's cytocidal action.
• To guide the development of novel amphotericin derivatives with improved therapeutic indices.

Main Methods:

• Investigated amphotericin aggregation and localization within yeast lipid bilayers.
• Analyzed the interaction of amphotericin with ergosterol in cellular membranes.
• Compared the cytocidal and membrane-permeabilizing activities of amphotericin.

Main Results:

• Amphotericin primarily forms large aggregates outside the cell membrane.
• These extramembranous aggregates kill yeast by extracting ergosterol.
• Ergosterol extraction, not ion channel formation, is the primary mechanism of action.
• This mechanism underlies amphotericin's resistance-refractory properties.

Conclusions:

• Amphotericin's antifungal action stems from ergosterol extraction, challenging the ion channel model.
• This finding provides a basis for designing amphotericin derivatives that separate toxicity from efficacy.
• Development is underway for novel amphotericin analogs targeting yeast specifically, sparing human cells.